The Changes of Ryodoraku and HRV After PPI Treatment in GERD Patients
Status:
Unknown status
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
Gastroesophageal reflux disease(GERD) mainly related to the reflux of stomach content induced
by the dysfunction of lower esophageal sphincter. Proton pump inhibitors (PPI) can
effectively block gastric acid secretion but the drug reactions and the degree of improvement
in symptoms are sometimes unpredictable. The aim of this study is to investigate the
association between the clinical efficacy of PPI in patients with GERD and the personal
physical status by Ryodoraku and ANSWatch.